Veracyte, Inc.
Veracyte, Inc.（VCYT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · VCYT · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
52
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Veracyte, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
VCYT 季度内部人买卖趋势
VCYT 内幕交易卖出 · VCYT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · VCYT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
VCYT 高管卖出股份 · VCYT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | McGuire Annie EVP, General Counsel | Other | 3,292 | $157K | Form 4 |
| Jun 4, 2026 | McGuire Annie EVP, General Counsel | Sale | 1,400 | $69K | Form 4 |
| Jun 4, 2026 | McGuire Annie EVP, General Counsel | Sale | 1,776 | $89K | Form 4 |
| Jun 2, 2026 | Wygant Jonathan VP, Chief Accounting Officer | Other | 1,361 | $65K | Form 4 |
| Jun 2, 2026 | Chambers Rebecca CFO | Other | 3,693 | $177K | Form 4 |
| Jun 4, 2026 | Chambers Rebecca CFO | Sale | 1,600 | $79K | Form 4 |
| Jun 4, 2026 | Chambers Rebecca CFO | Sale | 1,961 | $98K | Form 4 |
| Jun 2, 2026 | Febbo Phillip G. Chief Scientific & Med Officer | Other | 3,730 | $178K | Form 4 |
| Jun 4, 2026 | Stapley Marc CEO · Director | Option | 138,051 | $5.05M⚡ | Form 4 |
| Jun 2, 2026 | Stapley Marc CEO · Director | Other | 9,012 | $431K | Form 4 |
| Jun 4, 2026 | Stapley Marc CEO · Director | Sale | 138,051 | $6.92M⚡ | Form 4 |
| Jun 2, 2026 | Leite John Global Chief Commercial Off | Other | 4,059 | $194K | Form 4 |
| Jun 4, 2026 | Leite John Global Chief Commercial Off | Sale | 13,975 | $700K | Form 4 |
| May 22, 2026 | Wygant Jonathan VP, Chief Accounting Officer | Option | 24,000 | $595K | Form 4 |
| May 22, 2026 | Wygant Jonathan VP, Chief Accounting Officer | Sale | 24,000 | $1.09M⚡ | Form 4 |
| May 20, 2026 | EPSTEIN ROBERT S Director | Sale | 10,000 | $440K | Form 4 |
| May 6, 2026 | McGuire Annie SVP, General Counsel | Sale | 5,102 | $194K | Form 4 |
| May 6, 2026 | McGuire Annie SVP, General Counsel | Sale | 5,102 | $204K | Form 4 |
| Apr 10, 2026 | Haas Kevin Richard Chief Dev and Tech Officer | Award | 44,221 | — | Form 4 |
| Mar 6, 2026 | Wygant Jonathan VP, Chief Accounting Officer | Award | 10,525 | — | Form 4 |
| Mar 6, 2026 | McGuire Annie SVP, General Counsel | Award | 26,314 | — | Form 4 |
| Mar 6, 2026 | McGuire Annie SVP, General Counsel | Award | 32,892 | — | Form 4 |
| Mar 6, 2026 | Febbo Phillip G. Chief Scientific & Med Officer | Award | 6,578 | — | Form 4 |
| Mar 6, 2026 | Febbo Phillip G. Chief Scientific & Med Officer | Award | 29,603 | — | Form 4 |
| Mar 6, 2026 | Leite John Chief Commercial Officer-CLIA | Award | 6,578 | — | Form 4 |
Febbo Phillip G.
Chief Scientific & Med Officer
日期
Jun 2
股数
3,730
均价
$47.80
总金额
$178K
Wygant Jonathan
VP, Chief Accounting Officer
日期
May 22
股数
24,000
均价
$24.80
总金额
$595K
Wygant Jonathan
VP, Chief Accounting Officer
日期
May 22
股数
24,000
均价
$45.40
总金额
$1.09M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 VCYT 内幕交易
VCYT 内幕交易
Veracyte, Inc.（VCYT）内幕交易数据来源于公司内部人（包括McGuire Annie (EVP, General Counsel), Chambers Rebecca (CFO), Stapley Marc (CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。VCYT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Veracyte, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
VCYT 内幕交易 · 5个问题Veracyte, Inc.（VCYT）的内部人包括高管和董事，如McGuire Annie (EVP, General Counsel), Chambers Rebecca (CFO), Stapley Marc (CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026